{"id":24213,"date":"2026-06-25T15:42:13","date_gmt":"2026-06-25T19:42:13","guid":{"rendered":"https:\/\/www.ices.on.ca\/?post_type=journal_article&p=24213"},"modified":"2026-06-26T15:46:47","modified_gmt":"2026-06-26T19:46:47","slug":"the-burden-of-cardiovascular-disease-in-lymphoma-survivors","status":"publish","type":"journal_article","link":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/the-burden-of-cardiovascular-disease-in-lymphoma-survivors\/","title":{"rendered":"The burden of cardiovascular disease in lymphoma survivors: a population-based matched cohort study"},"content":{"rendered":"

Background<\/strong> \u2014 Cardiovascular disease (CVD) is a leading cause of morbidity in lymphoma survivors, yet contemporary data on CVD risk in survivors are limited.<\/p>\n

Objectives<\/strong> \u2014 This study assessed the hazard and absolute incidence of CVD in lymphoma survivors relative to cancer-free controls and evaluated temporal risks changes.<\/p>\n

Methods<\/strong> \u2014 We conducted a population-based matched cohort study of adults diagnosed with lymphoma in Ontario, Canada (2007-2018), matched 1:1 to cancer-free controls by age and sex. The primary outcome was CVD hospitalization, with follow-up through March 2024. Cause-specific hazard models accounted for death as a competing risk, and cumulative incidence functions assessed absolute risk. We tested the significance of an interaction term with calendar year to test for changes in CVD incidence between 2007 to 2010, 2011 to 2014, and 2015 to 2018.<\/p>\n

Results<\/strong> \u2014 Among 36,334 lymphoma survivors (median age 65; 45% female), the average adjusted HR for CVD hospitalization was 1.58 (95% CI: 1.52-1.64) compared to cancer-free controls; this HR was comparable to cardiovascular risk factors such as hypertension. The HR was highest in the first-year post-diagnosis but remained elevated for at least 10 years. The absolute difference in CVD risk between lymphoma survivors and controls at 5 years doubled from 1.1% (95% CI: 0.3%-1.9%) in 2007-2010 to 2.3% (95% CI: 1.6%-3.0%) in 2015-2018 (P = 0.02).<\/p>\n

Conclusions<\/strong> \u2014 Lymphoma survivors faced a persistently increased incidence of CVD compared to cancer-free individuals, and the absolute difference widened over the study period. The temporal risk patterns support current cardio-oncology guidelines recommending front-loaded and longitudinal cardiovascular surveillance.<\/p>\n","protected":false},"excerpt":{"rendered":"

Background \u2014 Cardiovascular disease (CVD) is a leading cause of morbidity in lymphoma survivors, yet contemporary data on CVD risk in survivors are limited. Objectives \u2014 This study assessed the hazard and absolute incidence of CVD in lymphoma survivors relative to cancer-free controls and evaluated temporal risks changes. Methods \u2014 We conducted a population-based matched […]<\/p>\n","protected":false},"template":"","migration-helper-automated":[],"migration-manual":[],"topic":[38,40],"migration-helper-qa-sample-set":[],"class_list":["post-24213","journal_article","type-journal_article","status-publish","hentry","topic-cancer-and-cancer-screening","topic-cardiovascular-disease"],"acf":{"citation":"Yu C, Chen Y, Halajha G, Prica A, Vijenthira A, Fang J, Austin PC, Thavendiranathan P, Abdel-Qadir H. JACC Adv<\/em>. 2026; 5(7): 102860. Epub 2026 Jun 25.","source_url":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102860","ices_scientist":[1385,1379],"site":[6733],"research_program":[6742],"news_release":"","journal_article":"","atlas":"","research_report":"","infographic":"","video":"","downloads":null,"links":null,"sitecore_item_id":"","sitecore_item_name":"","sitecore_field_values":"","previous_url":""},"yoast_head":"\nICES | The burden of cardiovascular disease in lymphoma survivors: a population-based matched cohort study<\/title>\n<meta name=\"description\" content=\"Background \u2014 Cardiovascular disease (CVD) is a leading cause of morbidity in lymphoma survivors, yet contemporary data on CVD risk in survivors are\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/the-burden-of-cardiovascular-disease-in-lymphoma-survivors\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICES | The burden of cardiovascular disease in lymphoma survivors: a population-based matched cohort study\" \/>\n<meta property=\"og:description\" content=\"Background \u2014 Cardiovascular disease (CVD) is a leading cause of morbidity in lymphoma survivors, yet contemporary data on CVD risk in survivors are\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/the-burden-of-cardiovascular-disease-in-lymphoma-survivors\/\" \/>\n<meta property=\"og:site_name\" content=\"ICES\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ICESOntario\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-26T19:46:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/the-burden-of-cardiovascular-disease-in-lymphoma-survivors\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/the-burden-of-cardiovascular-disease-in-lymphoma-survivors\\\/\",\"name\":\"ICES | The burden of cardiovascular disease in lymphoma survivors: a population-based matched cohort study\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\"},\"datePublished\":\"2026-06-25T19:42:13+00:00\",\"dateModified\":\"2026-06-26T19:46:47+00:00\",\"description\":\"Background \u2014 Cardiovascular disease (CVD) is a leading cause of morbidity in lymphoma survivors, yet contemporary data on CVD risk in survivors are\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/the-burden-of-cardiovascular-disease-in-lymphoma-survivors\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/the-burden-of-cardiovascular-disease-in-lymphoma-survivors\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/the-burden-of-cardiovascular-disease-in-lymphoma-survivors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Journal Articles\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"The burden of cardiovascular disease in lymphoma survivors: a population-based matched cohort study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"name\":\"ICES\",\"description\":\"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\"},\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\",\"name\":\"ICES\",\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"width\":\"676\",\"height\":\"618\",\"caption\":\"ICES\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ICESOntario\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ices-research-institute\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ICES | The burden of cardiovascular disease in lymphoma survivors: a population-based matched cohort study","description":"Background \u2014 Cardiovascular disease (CVD) is a leading cause of morbidity in lymphoma survivors, yet contemporary data on CVD risk in survivors are","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/the-burden-of-cardiovascular-disease-in-lymphoma-survivors\/","og_locale":"fr_FR","og_type":"article","og_title":"ICES | The burden of cardiovascular disease in lymphoma survivors: a population-based matched cohort study","og_description":"Background \u2014 Cardiovascular disease (CVD) is a leading cause of morbidity in lymphoma survivors, yet contemporary data on CVD risk in survivors are","og_url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/the-burden-of-cardiovascular-disease-in-lymphoma-survivors\/","og_site_name":"ICES","article_publisher":"https:\/\/www.facebook.com\/ICESOntario\/","article_modified_time":"2026-06-26T19:46:47+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/the-burden-of-cardiovascular-disease-in-lymphoma-survivors\/","url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/the-burden-of-cardiovascular-disease-in-lymphoma-survivors\/","name":"ICES | The burden of cardiovascular disease in lymphoma survivors: a population-based matched cohort study","isPartOf":{"@id":"https:\/\/www.ices.on.ca\/fr\/#website"},"datePublished":"2026-06-25T19:42:13+00:00","dateModified":"2026-06-26T19:46:47+00:00","description":"Background \u2014 Cardiovascular disease (CVD) is a leading cause of morbidity in lymphoma survivors, yet contemporary data on CVD risk in survivors are","breadcrumb":{"@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/the-burden-of-cardiovascular-disease-in-lymphoma-survivors\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/the-burden-of-cardiovascular-disease-in-lymphoma-survivors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/the-burden-of-cardiovascular-disease-in-lymphoma-survivors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ices.on.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Journal Articles","item":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/"},{"@type":"ListItem","position":3,"name":"The burden of cardiovascular disease in lymphoma survivors: a population-based matched cohort study"}]},{"@type":"WebSite","@id":"https:\/\/www.ices.on.ca\/fr\/#website","url":"https:\/\/www.ices.on.ca\/fr\/","name":"ICES","description":"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE","publisher":{"@id":"https:\/\/www.ices.on.ca\/fr\/#organization"},"alternateName":"Institute for Clinical Evaluative Sciences","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ices.on.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ices.on.ca\/fr\/#organization","name":"ICES","alternateName":"Institute for Clinical Evaluative Sciences","url":"https:\/\/www.ices.on.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","contentUrl":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","width":"676","height":"618","caption":"ICES"},"image":{"@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ICESOntario\/","https:\/\/www.linkedin.com\/company\/ices-research-institute\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article\/24213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article"}],"about":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/types\/journal_article"}],"acf:post":[{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/research_program\/6742"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/site\/6733"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1379"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1385"}],"wp:attachment":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/media?parent=24213"}],"wp:term":[{"taxonomy":"migration-helper-automated","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-automated?post=24213"},{"taxonomy":"migration-manual","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-manual?post=24213"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/topic?post=24213"},{"taxonomy":"migration-helper-qa-sample-set","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-qa-sample-set?post=24213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}